Unraveling the in vivo biological fate of mPEG2000-PDLLA2500-COOH diblock copolymers by LC-MS/MS based on CID in source technique
Analytica Chimica Acta · 2023
DOI: 10.1016/j.aca.2023.341375 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytica Chimica Acta, 2023. Verfasst von Meiyun Shi und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Life and Pharmaceutical Sciences, Dalian University of Technology, Panjin, China; Aim Honesty Biopharmaceutical Co. LTD, Dalian, China. Hauptthemen laut MEDLINE: Tandem Mass Spectrometry, Polymers. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: Fundamental Research Funds for the Central Universities, Dalian Science and Technology Innovation Fund, National Natural Science Foundation of China.
Abstract (Originalsprache)
Methoxy poly (ethylene glycol)-poly(D, L-lactic acid) (mPEG-PDLLA) is a biocompatible and amphiphilic diblock copolymer composed of a hydrophilic poly(ethylene glycol) block and a hydrophobic poly(D, L-lactic acid) block, which can self-assemble into micelles in aqueous solution. It is one of the most widely used diblock copolymers for drug delivery, drug solubilization and drug encapsulation. Fully characterizing the in vivo fate of mPEG-PDLLA diblock copolymers is important to promote the further development of polymer-based nanocarrier drug delivery systems. However, to date, a bioanalysis assay for simultaneous quantification of mPEG-PDLLA and mPEG has not been reported. In this study, we developed such a novel LC-MS/MS assay based on CID in source technique and used it to study the multiple-dose pharmacokinetic, tissue distribution and excretion of mPEG2000-PDLLA2500-COOH and mPEG2000 in rat after intravenous administration. The results indicate that mPEG2000-PDLLA2500-COOH and mPEG2000 are mainly distributed to the liver, lung, spleen and kidney after intravenous administration. mPEG2000-PDLLA2500-COOH is mostly excreted via the renal route in the form of mPEG2000. Overall, the results of this study provide a comprehensive and clear picture of the in vivo fate of mPEG2000-PDLLA2500-COOH which will be useful in evaluating the efficiency and safety of polymer-based nanocarrier drug delivery systems.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Life and Pharmaceutical Sciences, Dalian University of Technology, Panjin, China; Aim Honesty Biopharmaceutical Co. LTD, Dalian, China.
- School of Life and Pharmaceutical Sciences, Dalian University of Technology, Panjin, China.
- School of Life and Pharmaceutical Sciences, Dalian University of Technology, Panjin, China; Toll Biotech Co. LTD, Beijing, China.
- Aim Honesty Biopharmaceutical Co. LTD, Dalian, China.
- School of Life and Pharmaceutical Sciences, Dalian University of Technology, Panjin, China. Electronic address: leiyin@dlut.edu.cn.
Förderung
- Fundamental Research Funds for the Central Universities
- Dalian Science and Technology Innovation Fund
- National Natural Science Foundation of China
Zitieren
APA
Shi, M., Zheng, X., Jiang, H., Ge, Y., Zhang, N., Duan, X., Liu, Y., Xue, H., You, J., & Yin, L. (2023). Unraveling the in vivo biological fate of mPEG2000-PDLLA2500-COOH diblock copolymers by LC-MS/MS based on CID in source technique. Analytica Chimica Acta. https://doi.org/10.1016/j.aca.2023.341375
Vancouver
Shi M, Zheng X, Jiang H, Ge Y, Zhang N, Duan X, et al. Unraveling the in vivo biological fate of mPEG2000-PDLLA2500-COOH diblock copolymers by LC-MS/MS based on CID in source technique. Analytica Chimica Acta. 2023. doi:10.1016/j.aca.2023.341375
BibTeX
@article{Shi2023,
author = {Shi, Meiyun and Zheng, Xinyue and Jiang, Hui and Ge, Yuncheng and Zhang, Ning and Duan, Xujian and Liu, Yajun and Xue, Hongyu and You, Jiansong and Yin, Lei},
title = {Unraveling the in vivo biological fate of mPEG2000-PDLLA2500-COOH diblock copolymers by LC-MS/MS based on CID in source technique},
journal = {Analytica Chimica Acta},
year = {2023},
doi = {10.1016/j.aca.2023.341375}
}
EUVIMED